Kolltan Pharmaceuticals kolltan.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Kolltan Pharmaceuticals is a clinical-stage company focused on the discovery and development of novel, antibody-based drugs targeting receptor tyrosine kinases (RTKs). Focused primarily in oncology and backed by prominent thought leaders in RTK biology, Kolltan has reported clinical and preclinical data that its drug candidates can help overcome tumor resistance mechanisms associated with current tyrosine kinase inhibitors and seen in patients who have failed other cancer therapies.

Kolltan Pharmaceuticals is a clinical-stage company focused on the discovery and development of novel, antibody-based drugs targeting receptor tyrosine kinases (RTKs). Focused primarily in oncology and backed by prominent thought leaders in RTK biolo...Show all

Company (Acquired)

Phone: 203-773-3000

Fax: 203-773-1300

300 George Street
Suite 530
New Haven, 06511
Connecticut, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kolltan Pharmaceuticals $135M Nov 2, 2016
CGI Pharmaceuticals $61.1M Jun 25, 2010
Kanisa Pharmaceuticals $25M Dec 13, 2004
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kolltan Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-erbb antibodies and methods of use thereof Apr 10, 2015 Aug 18, 2020 Patent
Treatment of eosinophil or mast cell related disorders May 22, 2015 Mar 26, 2019 Patent
Anti-kit antibodies and uses thereof Nov 28, 2016 Jan 29, 2019 Patent
Anti-kit antibodies and uses thereof Mar 30, 2016 Mar 28, 2017 Patent
Anti-kit antibodies and uses thereof Jan 25, 2012 Jan 10, 2017 Patent
See all 8 patents